There are several potential biomarkers for diagnosis and prognosis for bladder cancer, including nuclear matrix protein-22 (NMP-22), human complement factor H-related protein, telomerase, fibrin degradation product, and hyaluronic acid (Dey, 2004). Here, NUMA1 is linked to urinary bladder carcinoma.